Shandong Zepu Medical Technology Co., Ltd.
Audit Report
Shanghui Shi Bao Zi (2026) No. 14930
Shanghui Certified Public Accountants (Special General Partnership)
Shanghai, China
To the Board of Directors of New Horizon Health Technology Group Co., Ltd.:
I. Audit Opinion
We have audited the financial statements of Shandong Zepu Medical Technology Co., Ltd. (hereinafter referred to as "Shandong Zepu"), including the consolidated and company balance sheets as of April 30, 2026, and December 31, 2025, the consolidated and company income statements, the consolidated and company cash flow statements, and the consolidated and company statements of changes in equity for the period from January 1, 2026, to April 30, 2026, and for the year 2025, as well as the related notes to the financial statements.
In our opinion, the accompanying financial statements have been prepared in all material respects in accordance with the Accounting Standards for Business Enterprises and fairly reflect the consolidated and company financial position of Shandong Zepu as of April 30, 2026, and December 31, 2025, as well as the consolidated and company operating results and cash flows for the period from January 1, 2026, to April 30, 2026, and for the year 2025.
II. Basis for Audit Opinion
We conducted our audit in accordance with the Auditing Standards for Certified Public Accountants of China. Our responsibilities under these standards are further described in the "Certified Public Accountant's Responsibilities for the Audit of the Financial Statements" section of the audit report. In accordance with the "Code of Ethics for Certified Public Accountants of China No. 1 — Independence Requirements for Financial Statement Audit and Review Engagements" and the Code of Professional Ethics for Certified Public Accountants of China, we are independent of Shandong Zepu and have fulfilled our other professional ethical responsibilities. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
III. Other Matters
Our report is intended solely for the purpose of the acquisition of Shandong Zepu by New Horizon Health Technology Group Co., Ltd. and is not suitable for any other purpose. This report shall not be provided to or used by any party other than the relevant parties for the aforementioned purpose.
IV. Responsibilities of Management and Those Charged with Governance for the Financial Statements
The management of Shandong Zepu (hereinafter referred to as "Management") is responsible for the preparation of financial statements in accordance with the Accounting Standards for Business Enterprises to achieve fair presentation, and for designing, implementing, and maintaining necessary internal controls to ensure that the financial statements are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, Management is responsible for assessing Shandong Zepu's ability to continue as a going concern, disclosing matters related to going concern (if applicable), and using the going concern basis of accounting unless Management intends to liquidate Shandong Zepu, cease operations, or has no realistic alternative but to do so.
Those charged with governance are responsible for overseeing Shandong Zepu's financial reporting process.
V. Certified Public Accountant's Responsibilities for the Audit of the Financial Statements
Our objective is to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an audit report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with auditing standards will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.